Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046005 · ClinicalTrials.gov registry record · NA
Personalized Risk Estimator for Rheumatoid Arthritis Family Study
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 238
- Enrollment target
NCT02046005: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02046005 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02046005, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how personalized risk factors for rheumatoid arthritis (RA) may impact willingness to change behaviors associated with RA. The investigators have developed a personalized risk estimator for RA based on demographics, family history, biomarkers and behaviors related to RA risk. Eligible participants have a first degree relative with RA but do not have RA themselves. Participants who meet eligibility and consent to the study will be randomized to receive either standard information about RA, the online personalized RA risk tool, or the online personalized RA risk tool with guidance from a health educator. Participants will be followed to measure willingness to change RA risk behaviors. The investigators hypothesize that participants who receive the online personalized RA risk tool and health education will be more willing to change RA risk behaviors compared to participants that receive standard RA information.
Primary Outcome
Measures willingness to change any of 4 RA-related behaviors compared to baseline using generalized estimating equations to compare the PRE-RA groups to the comparison arm.
Interventions
- BEHAVIORAL PRE-RA
- BEHAVIORAL PRE-RA Plus
- BEHAVIORAL General Rheumatoid Arthritis Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-07 |
| Phase | NA |
What the finished NCT02046005 record still lists
NCT02046005 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which PRE-RA is the first listed.
NCT02046005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02046005 about?
NCT02046005 is a clinical study titled "Personalized Risk Estimator for Rheumatoid Arthritis Family Study". The purpose of this study is to understand how personalized risk factors for rheumatoid arthritis (RA) may impact willingness to change behaviors associated with RA. The investigators have developed a personalized risk estimator for RA based on demographics, family history, biomarkers and behaviors ...
What is the current status of trial NCT02046005?
This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2014-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02046005?
The interventions under investigation include: PRE-RA (BEHAVIORAL), PRE-RA Plus (BEHAVIORAL), General Rheumatoid Arthritis Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02046005?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02046005's enrollment target sits among peer trials
238 459th of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia